India Drug Company Settles Massive False Claims Act Case
A large generic drug manufacturer based in India has agreed to settle a False Claims Act lawsuit by paying $350 million to resolve federal and state claims plus $150 million in criminal penalties. The federal lawsuit had alleged that Ranbaxy Laboratories Limited (“Ranbaxy”) had viola[...]